BRIEF-Aralez Pharmaceuticals' drug BLEXTEN receives Health Canada approval
April 25, 2016 at 07:12 AM EDT
* Aralez pharmaceuticals says Health Canada approved BLEXTEN for treatment of symptoms of seasonal allergic rhinitis, chronic spontaneous urticaria